{
    "organizations": [],
    "uuid": "594bab75f29e711756f204ed0f78c3d7f3b2574c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-ringpu-bio-technology-sees/brief-tianjin-ringpu-bio-technology-sees-fy-2018-q1-net-profit-up-20-pct-to-25-pct-idUSL3N1RN3M8",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Ringpu Bio-technology sees FY 2018 Q1 net profit up 20 pct to 25 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10(Reuters) - Tianjin Ringpu Bio-technology Co Ltd :\n* Sees FY 2018 Q1 net profit to increase by 20 percent to 25 percent, or to be 37.8 million yuan to 39.4 million yuan\n* Says FY 2017 Q1 net profit was 31.5 million yuan\n* The reasons for the forecast are sharply increased big customer business and veterinary drugs business and improved fund use efficiency Source text in Chinese: goo.gl/7BndU9 Further company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-10T17:02:00.000+03:00",
    "crawled": "2018-04-11T18:11:18.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "tianjin",
        "ringpu",
        "co",
        "ltd",
        "see",
        "fy",
        "q1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "q1",
        "net",
        "profit",
        "million",
        "yuan",
        "reason",
        "forecast",
        "sharply",
        "increased",
        "big",
        "customer",
        "business",
        "veterinary",
        "drug",
        "business",
        "improved",
        "fund",
        "use",
        "efficiency",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}